Multicef 125 mg/1.25 ml (Pediatric Drops)
Medicine Details
Category | Details |
---|---|
Generic | Cephradine |
Company | Desh pharmaceuticals ltd |
Also available as |
Indications
- Upper respiratory tract infections
- Lower respiratory tract infections
- Urinary tract infections
- Skin and soft tissue infections
Pharmacology
- Semisynthetic broad spectrum bactericidal antibiotic
- Active against gram-positive and gram-negative microorganisms
- Main site of action is the cell wall of bacteria
Dosage & Administration
- For Oral Administration - Adults:
- Urinary tract infections: 500mg four times daily or 1g twice daily
- Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily
- Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily
- For Oral Administration - Children:
- Total daily dose of 25 to 50mg/kg given in two or four equally divided doses
- Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly
- Maximum daily dosage: 4 gm
- For Injectable Administration - Adult: Usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily
- For Injectable Administration - Children: Dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection
Interaction
The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage
Contraindications
Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins
Side Effects
- Gastro-intestinal disturbances
- Hypersensitivity phenomena
- Skin reactions
- Glossitis
- Heartburn
- Dizziness
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Vaginitis
- Candida overgrowth
- Urticaria
- Skin rashes
- Joint pains
- Oedema
- Blood disorders
- Fever
- Anaphylaxis
- Confusion
- Liver enzyme disturbances
- Transient hepatitis
- Reversible interstitial nephritis
- Elevation of blood urea nitrogen
- Elevation of serum creatinine
- Elevation of alanine aminotransferase
- Elevation of aspartate aminotransferase
- Elevation of total bilirubin
- Elevation of alkaline phosphatase
Pregnancy & Lactation
Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers
Precautions & Warnings
- Prolonged use may result in the development of superinfection
- Should be administered with care to patients hypersensitive to penicillins
- May cause a positive result in Coombs' testing
- May cause a false positive urine glucose result when Benedict's or Fehling's solutions or tablets such as Clinitest are used in the testing
- Dosage adjustment is necessary in renal impairment
- Contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine
Use in Special Populations
- Renal Impairment: Doses recommended based on creatinine clearance
- Pediatric Dosages: Should not exceed those specified for adults, regardless of severity of infection
Overdose Effects
Non-specific symptoms include nausea, vomiting, diarrhea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested
Therapeutic Class
First generation Cephalosporins
Storage Conditions
Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days if kept in a refrigerator. Injection solutions should be used within 2 hours when kept at room temperature. Solutions retain potency for 12 hours when stored at 5°C
Related Brands
- Abac 500 mg (Capsule) - chemist-laboratories-ltd
- Abac 125 mg/5 ml (Powder for Suspension) - chemist-laboratories-ltd
- Abac 125 mg/1.25 ml (Pediatric Drops) - chemist-laboratories-ltd
- Acefra 500 mg (Capsule) - apollo-pharmaceutical-ltd
- Acefra 125 mg/5 ml (Powder for Suspension) - apollo-pharmaceutical-ltd